These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 29055387)

  • 1. The colon revisited or the key to wellness, health and disease.
    Gonzalez-Correa CA; Mulett-Vásquez E; Miranda DA; Gonzalez-Correa CH; Gómez-Buitrago PA
    Med Hypotheses; 2017 Oct; 108():133-143. PubMed ID: 29055387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic syndrome].
    Halmos T; Suba I
    Orv Hetil; 2016 Jan; 157(1):13-22. PubMed ID: 26708682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes.
    Tomasello G; Tralongo P; Damiani P; Sinagra E; Di Trapani B; Zeenny MN; Hussein IH; Jurjus A; Leone A
    World J Gastroenterol; 2014 Dec; 20(48):18121-30. PubMed ID: 25561781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Alteration of intestinal permeability: the missing link between gut microbiota modifications and inflammation in obesity?].
    Genser L; Poitou C; Brot-Laroche É; Rousset M; Vaillant JC; Clément K; Thenet S; Leturque A
    Med Sci (Paris); 2016 May; 32(5):461-9. PubMed ID: 27225918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary destabilisation of the balance between the microbiota and the colonic mucus barrier.
    Birchenough G; Schroeder BO; Bäckhed F; Hansson GC
    Gut Microbes; 2019; 10(2):246-250. PubMed ID: 30252606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can the gut be the missing piece in uncovering PD pathogenesis?
    Chapelet G; Leclair-Visonneau L; Clairembault T; Neunlist M; Derkinderen P
    Parkinsonism Relat Disord; 2019 Feb; 59():26-31. PubMed ID: 30448099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysbiosis and metabolic endotoxemia induced by high-fat diet.
    Netto Candido TL; Bressan J; Alfenas RCG
    Nutr Hosp; 2018 Dec; 35(6):1432-1440. PubMed ID: 30525859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain-gut-microbiota axis in Parkinson's disease.
    Mulak A; Bonaz B
    World J Gastroenterol; 2015 Oct; 21(37):10609-20. PubMed ID: 26457021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Gut microbiota and immune crosstalk in metabolic disease].
    Burcelin R
    Biol Aujourdhui; 2017; 211(1):1-18. PubMed ID: 28682223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Intestinal Barrier in Parkinson's Disease: Current State of Knowledge.
    van IJzendoorn SCD; Derkinderen P
    J Parkinsons Dis; 2019; 9(s2):S323-S329. PubMed ID: 31561386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of microbiota to the intestinal physicochemical barrier.
    Malago JJ
    Benef Microbes; 2015; 6(3):295-311. PubMed ID: 25273548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysbiotic events in gut microbiota: impact on human health.
    Schippa S; Conte MP
    Nutrients; 2014 Dec; 6(12):5786-805. PubMed ID: 25514560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential mechanisms for the emerging link between obesity and increased intestinal permeability.
    Teixeira TF; Collado MC; Ferreira CL; Bressan J; Peluzio Mdo C
    Nutr Res; 2012 Sep; 32(9):637-47. PubMed ID: 23084636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Could the beneficial effects of dietary calcium on obesity and diabetes control be mediated by changes in intestinal microbiota and integrity?
    Gomes JM; Costa JA; Alfenas RC
    Br J Nutr; 2015 Dec; 114(11):1756-65. PubMed ID: 26400630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential impact of gut microbiota on your health:Current status and future challenges.
    Sirisinha S
    Asian Pac J Allergy Immunol; 2016 Dec; 34(4):249-264. PubMed ID: 28042926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intestinal Microbiota and Celiac Disease: Cause, Consequence or Co-Evolution?
    Cenit MC; Olivares M; Codoñer-Franch P; Sanz Y
    Nutrients; 2015 Aug; 7(8):6900-23. PubMed ID: 26287240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice.
    Cani PD; Bibiloni R; Knauf C; Waget A; Neyrinck AM; Delzenne NM; Burcelin R
    Diabetes; 2008 Jun; 57(6):1470-81. PubMed ID: 18305141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intestinal microbiota in health and disease: role of bifidobacteria in gut homeostasis.
    Tojo R; Suárez A; Clemente MG; de los Reyes-Gavilán CG; Margolles A; Gueimonde M; Ruas-Madiedo P
    World J Gastroenterol; 2014 Nov; 20(41):15163-76. PubMed ID: 25386066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enteric Delivery of Regenerating Family Member 3 alpha Alters the Intestinal Microbiota and Controls Inflammation in Mice With Colitis.
    Darnaud M; Dos Santos A; Gonzalez P; Augui S; Lacoste C; Desterke C; De Hertogh G; Valentino E; Braun E; Zheng J; Boisgard R; Neut C; Dubuquoy L; Chiappini F; Samuel D; Lepage P; Guerrieri F; Doré J; Bréchot C; Moniaux N; Faivre J
    Gastroenterology; 2018 Mar; 154(4):1009-1023.e14. PubMed ID: 29133078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysbiotic Proteobacteria expansion: a microbial signature of epithelial dysfunction.
    Litvak Y; Byndloss MX; Tsolis RM; Bäumler AJ
    Curr Opin Microbiol; 2017 Oct; 39():1-6. PubMed ID: 28783509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.